Results 91 to 100 of about 338,121 (356)

Drugs affecting HbA1c levels

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Glycated hemoglobin (HbA1c) is an important indicator of glycemic control in diabetes mellitus, based on which important diagnostic and therapeutic decisions are routinely made. However, there are several situations in which the level of HbA1c may not faithfully reflect the glycemic control in a given patient.
Ranjit Unnikrishnan   +2 more
openaire   +3 more sources

External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Diuretic resistance in worsening heart failure (HF) is associated with poorer outcomes and, although common, can be challenging to identify. The recently developed BAN‐ADHF score can potentially identify patients with worsening HF at risk of diuretic resistance.
Dominic M. Alfonso   +10 more
wiley   +1 more source

Exploratory analysis of the relationships among different methods of assessing adherence and glycemic control in youth with type 1 diabetes mellitus [PDF]

open access: yes, 2011
Objectives: The present study examined four methods of assessing diabetes adherence (self-report, diary measure, electronic monitoring, and provider rating) within a population of youth with Type I Diabetes Mellitus (T1DM).
Alemzadeh, Ramin   +3 more
core   +1 more source

Hyperglycemia Has a Greater Impact on Left Ventricle Function in South Asians Than in Europeans [PDF]

open access: yes, 2013
OBJECTIVE Diabetes is associated with left ventricular (LV) diastolic and systolic dysfunction. South Asians may be at particular risk of developing LV dysfunction owing to a high prevalence of diabetes.
Chaturvedi, N   +11 more
core   +1 more source

A Stacked Ensemble Multi‐Label Model for Predicting Co‐Occurring Microvascular and Macrovascular Complications in Type 2 Diabetes

open access: yesChronic Diseases and Translational Medicine, EarlyView.
Feature importance for predicting multiple diabetes complications based on a Stacking‐Classifier Chain model. Abstract Background Type 2 diabetes mellitus (T2DM) leads to severe microvascular and macrovascular complications. Traditional single‐label prediction models fail to capture their co‐occurring nature.
Maryam Zamani   +3 more
wiley   +1 more source

PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF UNCONTROLLED AND CONTROLLED TYPE 2 DIABETES MELLITUS

open access: yesPakistan Armed Forces Medical Journal, 2019
Objectives: To determine the presence of non-alcoholic fatty liver disease in patients of uncontrolled and controlled type 2 diabetes mellitus. Study Design: Cross sectional study.
Aqeela Rashid   +4 more
doaj  

Prospective study of hyperglycemia and its impact on the causation of severe exacerbations in chronic obstructive pulmonary disease (COPD) patients attending a tertiary care hospital

open access: yesJournal of Applied Pharmaceutical Research, 2023
Background: Hyperglycemic states are always associated with sudden onset of illnesses of both infectious and non-infectious nature. Chronic obstructive pulmonary disease is a chronic, lifelong suffering illness with sudden exacerbations.
doaj   +1 more source

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction [PDF]

open access: yes, 2017
Hemoglobin glycation index (HGI), calculated as the difference between the observed value of HbA1 and the predicted HbA1c based on plasma glucose concentration, is a measure of the individual tendency toward non-enzymatic hemoglobin glycation which has ...
Andreozzi F   +6 more
core   +1 more source

Use of HbA1c in the diagnosis of diabetes [PDF]

open access: yesBMJ, 2012
Be aware of clinical circumstances in which results may mislead Before 2010, guidelines recommended the measurement of blood glucose for diagnosing diabetes. Improved standardisation in the measurement of glycated haemoglobin (HbA1c) and wider availability of the assay led to a recommendation in 2011 by the World Health Organization that HbA1c should ...
openaire   +3 more sources

GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes

open access: yesChronic Diseases and Translational Medicine, EarlyView.
Endogenous GLP‐1 and exogenous GLP‐1 RAs activate GLP‐1R‐expressing vagal afferents in the portal vein, projecting to the nucleus tractus solitarius (NTS). This input engages brainstem–hypothalamic circuits that regulate metabolic homeostasis. Hypothalamic efferent vagal output to the liver suppresses lipogenesis, enhances triglyceride export, and ...
Gabriel Amorim Moreira Alves   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy